Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

Cited In for PubMed (Select 17652175)

1.

An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease.

Kizuka Y, Kitazume S, Fujinawa R, Saito T, Iwata N, Saido TC, Nakano M, Yamaguchi Y, Hashimoto Y, Staufenbiel M, Hatsuta H, Murayama S, Manya H, Endo T, Taniguchi N.

EMBO Mol Med. 2015 Jan 15;7(2):175-89. doi: 10.15252/emmm.201404438.

2.

MyD88 is dispensable for cerebral amyloidosis and neuroinflammation in APP/PS1 transgenic mice.

Weitz TM, Gate D, Rezai-Zadeh K, Town T.

Am J Pathol. 2014 Nov;184(11):2855-61. doi: 10.1016/j.ajpath.2014.07.004. Epub 2014 Aug 28.

PMID:
25174876
3.

Autophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome.

Cho MH, Cho K, Kang HJ, Jeon EY, Kim HS, Kwon HJ, Kim HM, Kim DH, Yoon SY.

Autophagy. 2014 Oct 1;10(10):1761-75. doi: 10.4161/auto.29647. Epub 2014 Jul 22.

PMID:
25126727
4.

Differential effects of methoxy group on the interaction of curcuminoids with two major ligand binding sites of human serum albumin.

Sato H, Chuang VT, Yamasaki K, Yamaotsu N, Watanabe H, Nagumo K, Anraku M, Kadowaki D, Ishima Y, Hirono S, Otagiri M, Maruyama T.

PLoS One. 2014 Feb 3;9(2):e87919. doi: 10.1371/journal.pone.0087919. eCollection 2014.

5.

Neuroinflammation and brain functional disconnection in Alzheimer's disease.

Baglio F, Saresella M, Preti MG, Cabinio M, Griffanti L, Marventano I, Piancone F, Calabrese E, Nemni R, Clerici M.

Front Aging Neurosci. 2013 Nov 25;5:81. doi: 10.3389/fnagi.2013.00081. eCollection 2013.

6.

Recognition of bisecting N-acetylglucosamine: structural basis for asymmetric interaction with the mouse lectin dendritic cell inhibitory receptor 2.

Nagae M, Yamanaka K, Hanashima S, Ikeda A, Morita-Matsumoto K, Satoh T, Matsumoto N, Yamamoto K, Yamaguchi Y.

J Biol Chem. 2013 Nov 22;288(47):33598-610. doi: 10.1074/jbc.M113.513572. Epub 2013 Oct 9.

7.

Bisdemethoxycurcumin Increases Sirt1 to Antagonize t-BHP-Induced Premature Senescence in WI38 Fibroblast Cells.

Li YB, Zhong ZF, Chen MW, Bao JL, Wu GS, Zhang QW, Lee SM, Hoi PM, Wang YT.

Evid Based Complement Alternat Med. 2013;2013:851714. doi: 10.1155/2013/851714. Epub 2013 Sep 2.

8.

Fabrication and Evaluation of Curcumin-loaded Nanoparticles Based on Solid Lipid as a New Type of Colloidal Drug Delivery System.

Chen J, Dai WT, He ZM, Gao L, Huang X, Gong JM, Xing HY, Chen WD.

Indian J Pharm Sci. 2013 Mar;75(2):178-84.

9.

Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer's disease in Han Chinese.

Wang YL, Tan MS, Yu JT, Zhang W, Hu N, Wang HF, Jiang T, Tan L.

J Neuroinflammation. 2013 Aug 20;10(1):101. doi: 10.1186/1742-2094-10-101.

10.

Dietary supplementation with two Lamiaceae herbs-(oregano and sage) modulates innate immunity parameters in Lumbricus terrestris.

Vattem DA, Lester C, Deleon R, Jamison B, Maitin V.

Pharmacognosy Res. 2013 Jan;5(1):1-9. doi: 10.4103/0974-8490.105636.

11.

Bisdemethoxycurcumin inhibits PDGF-induced vascular smooth muscle cell motility and proliferation.

Hua Y, Dolence J, Ramanan S, Ren J, Nair S.

Mol Nutr Food Res. 2013 Sep;57(9):1611-8. doi: 10.1002/mnfr.201200852. Epub 2013 Apr 2.

12.

Animal Models of Alzheimer's Disease: Utilization of Transgenic Alzheimer's Disease Models in Studies of Amyloid Beta Clearance.

Malm T, Magga J, Koistinaho J.

Curr Transl Geriatr Exp Gerontol Rep. 2012 Mar;1(1):11-20. Epub 2012 Jan 19.

13.

1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients.

Mizwicki MT, Liu G, Fiala M, Magpantay L, Sayre J, Siani A, Mahanian M, Weitzman R, Hayden EY, Rosenthal MJ, Nemere I, Ringman J, Teplow DB.

J Alzheimers Dis. 2013;34(1):155-70. doi: 10.3233/JAD-121735.

14.

Natural Modulators of Amyloid-Beta Precursor Protein Processing.

Zhang C, Tanzi RE.

Curr Alzheimer Res. 2012 Sep 13. [Epub ahead of print]

15.

Fractalkine Mediates Communication between Pathogenic Proteins and Microglia: Implications of Anti-Inflammatory Treatments in Different Stages of Neurodegenerative Diseases.

Desforges NM, Hebron ML, Algarzae NK, Lonskaya I, Moussa CE.

Int J Alzheimers Dis. 2012;2012:345472. doi: 10.1155/2012/345472. Epub 2012 Aug 5.

16.

Multi-layer polymeric implants for sustained release of chemopreventives.

Aqil F, Jeyabalan J, Kausar H, Bansal SS, Sharma RJ, Singh IP, Vadhanam MV, Gupta RC.

Cancer Lett. 2012 Dec 29;326(1):33-40. doi: 10.1016/j.canlet.2012.07.017. Epub 2012 Jul 20.

17.
18.

Chemotactic and mitogenic stimuli of neuronal apoptosis in patients with medically intractable temporal lobe epilepsy.

Fiala M, Avagyan H, Merino JJ, Bernas M, Valdivia J, Espinosa-Jeffrey A, Witte M, Weinand M.

Pathophysiology. 2013 Feb;20(1):59-69. doi: 10.1016/j.pathophys.2012.02.003. Epub 2012 Mar 22.

19.

Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.

Wyss-Coray T, Rogers J.

Cold Spring Harb Perspect Med. 2012 Jan;2(1):a006346. doi: 10.1101/cshperspect.a006346. Review.

20.

Lack of efficacy of curcumin on neurodegeneration in the mouse model of Niemann-Pick C1.

Borbon IA, Hillman Z, Duran E Jr, Kiela PR, Frautschy SA, Erickson RP.

Pharmacol Biochem Behav. 2012 Mar;101(1):125-31. doi: 10.1016/j.pbb.2011.12.009. Epub 2011 Dec 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk